The global biotech industry is regarded as the growth market par excellence. According to market estimates, the industry’s sales in 2015 are expected to reach € 228 billion, and by 2020 the biotech market is expected to more than double to € 515 billion.
Germany is also represented in this area with companies such as MorphoSys, which is considered one of the most innovative companies in this market segment. Compared to the top 10 biotech companies, MorphoSys is still relatively small with a market capitalization of around € 2.0 billion.
At the top of the world, biotech companies are valued at over $ 100 billion. These are the top 10 leading biotech companies.
10. Valeant Pharmaceuticals (market value: € 34 billion)
Canadian-based Valeant Pharmaceuticals International previously served as Biovail Corporation. Today, the company develops and produces patented drugs, as well as generics for the fields of neurology, dermatology and ophthalmology. Valeant, founded in 1960, has also grown through acquisitions. In mid- 2014, both the Akorn subsidiary ECR Pharmaceuticals and PreCision Dermatoly were taken over.
9. Teva Pharmaceutical Industries (market value: € 38.7 billion)
Israel-based Teva Pharmaceutical Industries was founded back in 1901. Today, the company is not only one of the top 10 pharmaceutical companies, but is also represented in the biotechnology segment. Together with Active Biotech, Teva develops Nerventra, a drug used to treat multiple sclerosis.
8. Shire plc (market value: € 40.4 billion)
Founded in 1986, Shire plc is actually a British company, but operates from Dublin / Ireland. Shire is considered one of the world’s leading biopharmaceutical specialists. The company specializes in the
treatment of attention deficit hyperactivity disorder (ADHD), gastrointestinal diseases, human genetic therapies and regenerative medicine. Mid-2014, Shire snatched the pharmaceutical group AbbVie for €
7. Allergan (market value: € 41.7 billion)
Allergan, based in Irvine / USA, is world-famous for its product Botox. This is used under the brand Botox Cosmetic and Vistabel mainly in facial care and wrinkle control. Allergan is also represented with Biologics products. In 2014, Valeant made a $ 52 billion (€ 40.9 billion) takeover bid for Allergan. At Allergan rejects the hostile takeover.
6. Actavis plc (market value: € 50.8 billion)
Based in Dublin, Ireland, Actavis plc specializes in generic medicines and is considered a leader in this market segment. Actavis markets around 1,000 generic products in more than 60 countries worldwide. In recent years, Actavis has grown aggressively through acquisitions. In early 2014, Actavis announced the acquisition of pharmaceutical specialist Forest Labs for $ 25 billion (€ 19.7 billion), creating a new biopharma powerhouse.
5. Celgene Corporation (market value: € 59.5 billion)
US-based Celgene Corporation is a biopharmaceutical specialist specializing in the development of drugs and medicines for cancer and immune system diseases. Celgene invests up to 30% of its sales in research and development. Celgene’s key medicines include REVLIMID, Vidaza, Thalomid, Abraxane and Istodax.
4. Biogen (market value: € 62 billion)
Massachusetts-based Biogen is considered one of the world’s leading biotech companies. The company emerged in 2003 from the merger of Biogen and Idec Pharmaceuticals. Biogen itself was originally founded in 1978 as Biogen NV. Today, Biogen specializes in the treatment of multiple sclerosis and Alzheimer’s disease.
3. Amgen (market value: € 84.3 billion)
Amgen, based in Thousand Oaks, California, has been one of the top 10 largest biotech companies for years. The company’s beginnings date back to 1980, when the company was still known as Applied Molecular Genetics – in 1983 the name changed to Amgen. Following the $ 16 billion (€ 12.6 billion)
acquisition of Immunex in 2001, Amgen paid approximately $ 10.4 billion (€ 8.2 billion) in 2013 for the smaller rival Onyx – with this Amgen made sometimes the largest takeovers in the biotech industry.
2. Novo Nordisk (market value: € 100 billion)
The Danish Novo Nordisk was founded in 1923. Novo Nordisk specializes in diabetes medicines (insulin) and biopharma products (hormone preparations). In the area of diabetes medicines, Novo Nordisk is
considered the world market leader. In recent years, Novo Nordisk has invested a further € 134 million in the construction of a new biopharmaceutical production facility in Kalundorg, Denmark, to further
expand the business.
1. Gilead Sciences (stock market value: € 129.2 billion)
Gilead Sciences, based in Foster City, California, is a leading global pharmaceutical and biotech company. Gilead Sciences researches in particular therapies for the fight against HIV, hepatitis B, hepatitis C and
influenza viruses. Gilead Sciences is already top dog in the HIV market. In 2011, Gilead Sciences strengthened its position by acquiring biotech company Pharmasset for $ 11 billion (€ 8.66 billion), which has given Gilead a new leg (hepatitis C). The hepatitis C tablet Sovaldi is considered the most
expensive tablet in the world at 700 €.